The forecasted pharmaceutical goods exports in China indicate steady growth from 2024 to 2028, starting at 2.3 billion USD in 2024 and increasing to 2.67 billion USD by 2028. The export figures for 2023 were actual, providing a baseline for future projections. The year-on-year variation for the forecasted period shows consistent growth, with an average annual growth rate (CAGR) calculated over the five years reflecting stable positive trends.
Trends to watch for:
• Increased global demand for pharmaceuticals due to aging populations and rising healthcare needs.
• Potential impact of regulatory changes and trade policies on export volumes.
• Technological advancements and innovation in the pharmaceutical industry driving export growth.
